SANDERCOCK BRETT (Chief Financial Officer) sold 3.3% of their position (3K shares) of RESMED INC on the open market
Open‑market sale worth $823.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/3/2025ACC: 0000943819-25-000084
Officer· Chief Financial Officer
Since Mar 2026
-3K
Net shares
Net seller
$823.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2K acquired · 5K disposed
Non-Derivative Transactions2
ResMed Common Stock
Direct
Shares
+2K
Price / share
$101.64
Trade value
$203.28K
% of position
2.3%
10/1/2025
87.75K→89.75K
ResMed Common Stock
Direct
Shares
−3K
Price / share
$274.36
Trade value
$823.08K
% of position
3.3%
10/1/2025
89.75K→86.75K
Total
Net shares
−1K
Net value
-$619.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Direct | 10/1/2025 | M · Option Exercise | +2K | $101.64 | $203.28K | 2.3% | 87.75K | 89.75K |
| ResMed Common Stock Direct | 10/1/2025 | S · Sale | −3K | $274.36 | $823.08K | 3.3% | 89.75K | 86.75K |
| Total | −1K | -$619.80K | ||||||
Derivative Transactions1
ResMed Common Stock Options
Direct
Converts to
ResMed Common Stock
2K shares
Shares
−2K
Strike price
101.64
Held after
2K
Exercisable
—
10/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| ResMed Common Stock Options Direct | ResMed Common Stock2K shares | 10/1/2025 | M · Option Exercise | −2K | 101.64 | — | 2K |